Parental Subsidies for Diagnostics
Executive Summary
Wrapped in a modish genomic gown, in vitro diagnostics are back in fashion. No sooner has Applera (formerly PE Corp.) announced a major new initiative in diagnostics than diaDexus files for an IPO. But these aren't your grandfather's diagnostics companies: they start life with huge pharmaceutical subsidies in terms of genomic data and financing.
You may also be interested in...
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.